FDA Updates Tivicay and Triumeq Labeling
"The Tivicay (dolutegravir) and Triumeq (abacavir/dolutegravir/lamivudine) product labeling was updated with drug-drug interaction information."
The updated labeling is available at the FDA website.
More information is available:
FDA: Press release
AIDSinfo: Patient fact sheet on Tivicay
AIDSinfo: Patient fact sheet on Triumeq
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - Category: Infectious Diseases Source Type: news